Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Machine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsPreferred Shares RepurchasedShares Repurchased
Ratios

PharmaCyte Biotech (PMCB) Shares Repurchased (2022 - 2026)

PharmaCyte Biotech (PMCB) has disclosed Shares Repurchased for 4 consecutive years, with $171543.0 as the latest value for Q2 2025.

  • On a quarterly basis, Shares Repurchased fell 85.4% to $171543.0 in Q2 2025 year-over-year; TTM through Oct 2025 was $396568.0, a 89.35% decrease, with the full-year FY2025 number at $2.5 million, down 90.98% from a year prior.
  • Shares Repurchased was $171543.0 for Q2 2025 at PharmaCyte Biotech, down from $225025.0 in the prior quarter.
  • In the past five years, Shares Repurchased ranged from a high of $26.5 million in Q3 2023 to a low of $164953.0 in Q4 2023.
  • A 4-year average of $3.7 million and a median of $1.3 million in 2024 define the central range for Shares Repurchased.
  • Peak YoY movement for Shares Repurchased: skyrocketed 1165.39% in 2023, then tumbled 97.19% in 2024.
  • PharmaCyte Biotech's Shares Repurchased stood at $3.4 million in 2022, then crashed by 95.13% to $164953.0 in 2023, then surged by 750.87% to $1.4 million in 2024, then plummeted by 87.78% to $171543.0 in 2025.
  • Per Business Quant, the three most recent readings for PMCB's Shares Repurchased are $171543.0 (Q2 2025), $225025.0 (Q1 2025), and $1.4 million (Q4 2024).